Amphastar Pharmaceuticals
AMPH
AMPH
134 hedge funds and large institutions have $442M invested in Amphastar Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 46 increasing their positions, 36 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
3.6% more ownership
Funds ownership: 44.61% → 48.21% (+3.6%)
Holders
134
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$12.1M | |
| 2 | +$2.47M | |
| 3 | +$2.43M | |
| 4 |
MCM
Matarin Capital Management
New York
|
+$2.41M |
| 5 |
MAM
Martingale Asset Management
Boston,
Massachusetts
|
+$1.95M |
Top Sellers
| 1 | -$2.43M | |
| 2 | -$1.23M | |
| 3 | -$1.21M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$1.02M |
| 5 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$688K |